PATENT CLAIM ANALYSIS

Application Number: 15761060
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["514", "025000"]

Abstract:
The invention relates to the use of a compound of formula (I), or a composition containing the compound, as glutaminyl cyclase (QC) inhibitor and to methods of preparation.

Claim (Index 10):
The use of the composition according to  claim 5 , wherein the composition comprises a further therapeutic agent selected from the group comprising acetylcholinesterase inhibitors, NMDA-receptor antagonists, neuroprotectors, anti-Parkinson medicaments, antidepressives, anxiolytic medicaments, antipsychotic medicaments, medicaments against multiple sclerosis, ACE inhibitors, diuretics, \u03b2-receptor blockers, nitrates, cardiac glycosides, calcium antagonists, lipid reducers, aggregation inhibitors, antihypoxaemics, coagulation inhibitors, cytostatics and antibiotics.

Metadata:
- Claim Count in Document: 27.0
- Percentile: 90.0
- Lexical Diversity: 1.34615
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['12139781', '14237537', '14862245', '11051760', '13044678']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7435637314080619
- 35 USC 102 Novelty (BERT): 0.5026828534123919
- Combined Prediction Score: 0.7194756436084949
- Mean Citation Score: 198.042986
- Max Citation Score: 224.41214
- Similarity Product: 143.11254882072566

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test